Could a TB vaccine stop diabetes before it starts?
NCT ID NCT05591339
First seen Feb 18, 2026 · Last updated May 22, 2026 · Updated 14 times
Summary
This study in Guinea-Bissau tests whether the BCG vaccine (normally used for tuberculosis) can prevent or delay type 2 diabetes in 200 adults with pre-diabetes. Researchers believe the vaccine may reduce inflammation and insulin resistance. The goal is to find a low-cost way to curb the growing diabetes epidemic in low-income countries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bandim Health Project
Bissau, 1004, Guinea-Bissau
Conditions
Explore the condition pages connected to this study.